Research
New studies and what they mean for practice, read by physicians.
Research · Clinical Trials
An AI-designed drug moved six aging clocks. In IPF patients. For 12 weeks.
Proteomic substudy of the Phase 2a IPF trial of rentosertib, Insilico’s TNIK inhibitor (n=42).
Research · Clinical Trials
Launching the First Longevity Clinical Trial Network
Longevity medicine is emerging fast. Yet as the field grows, so does the need for validation. Today, most interventions are supported by small studies, animal data, or anecdotal success.
The Sunday edition.
The week in longevity medicine, every Sunday.
Free, delivered by Substack. Unsubscribe any time.